LCG
BDSI

Lisanti Capital Growth’s BioDelivery Sciences International, Inc. BDSI Stock Holding History

Lisanti Capital Growth’s Portfolio BDSI Stock Details BDSI Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2014
Q4 		– Sell
-72,055
Closed -$1.23M – 127
2014
Q3 		$1.23M Buy
+72,055
New +$1.05M 0.62% 75

Other funds holding BDSI

Federated Hermes
Federated Hermes Pittsburgh, Pennsylvania $61.5B AUM 30.7% 1-Year Est. Return
Invesco
Invesco Atlanta, Georgia $1.02T AUM 30.18% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
BC
Broadfin Capital New York $747M AUM 100.56% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
ORI
Oak Ridge Investments Chicago, Illinois $1.77B AUM 63.16% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BIT
BlackRock Institutional Trust San Francisco, California $675B AUM 16.07% 1-Year Est. Return
BFA
BlackRock Fund Advisors San Francisco, California $542B AUM 18.13% 1-Year Est. Return
Wells Fargo
Wells Fargo San Francisco, California $530B AUM 22.01% 1-Year Est. Return

Lisanti Capital Growth's BDSI Position: Q4 2014 in Review

Lisanti Capital Growth sold out of BioDelivery Sciences International, Inc. (BDSI) in Q4 2014, closing a stake of 72,055 shares — an estimated $1.23M sold.

Lisanti Capital Growth first reported a position in BDSI in Q3 2014 and held it in 1 quarter. The position peaked at $1.23M in Q3 2014. 135 funds tracked by Wall St. Rank hold BDSI as of Q4 2014.

  • Lisanti Capital Growth reported no remaining BioDelivery Sciences International, Inc. position as of Q4 2014 after selling out during the quarter.
  • Lisanti Capital Growth sold 72,055 BioDelivery Sciences International, Inc. shares in Q4 2014, an estimated $1.23M.
  • Lisanti Capital Growth first reported a position in BioDelivery Sciences International, Inc. in Q3 2014 and held it in 1 quarter.
  • Lisanti Capital Growth's BioDelivery Sciences International, Inc. position peaked at $1.23M in Q3 2014.
  • 135 funds tracked by Wall St. Rank held BioDelivery Sciences International, Inc. as of Q4 2014.

Based on Lisanti Capital Growth's 13F filing for Q4 2014, filed 10 Feb 2015.